Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chimeric antigen receptor and chimeric antigen receptor T cells targeting CD133, preparation method of chimeric antigen receptor T cells and application of chimeric antigen receptor and chimeric antigen receptor T cells

A chimeric antigen receptor and targeting technology, applied in the field of medical biology, can solve the problems of easy tumor recurrence and side reactions, and achieve the effects of high transcription efficiency, highly tissue-specific expression, and high infection efficiency.

Inactive Publication Date: 2019-12-03
SHENZHEN BINDEBIOTECH CO LTD
View PDF6 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, the incidence of colorectal cancer ranks second among malignant tumors in Western countries. Although radiotherapy, chemotherapy, and surgery have significantly prolonged the life of patients, there are still problems such as tumor recurrence and serious side effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chimeric antigen receptor and chimeric antigen receptor T cells targeting CD133, preparation method of chimeric antigen receptor T cells and application of chimeric antigen receptor and chimeric antigen receptor T cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0074] A method for preparing chimeric antigen receptor T cells targeting CD133, comprising the following steps:

[0075] (1) Prepare the gene sequence of chimeric antigen receptor CAR-CD133 targeting CD133

[0076] The genes encoding the signal peptide, the single-chain antibody targeting CD133, the hinge region of CD8α, the transmembrane region of CD8, the signal region of CD27, and the signal region of CD3ζ were prepared respectively. The genes encoding the signal peptide are shown in SEQ ID NO: 15, and the The coding gene of the single-chain antibody targeting CD133 is shown in SEQ ID NO: 2, the coding gene of the CD8α hinge region is shown in SEQ ID NO: 7, and the coding gene of the CD8 transmembrane region is shown in SEQ ID NO 9, the coding gene of the CD27 signal region is shown in SEQ ID NO: 11, and the coding gene of the CD3ζ signal region is shown in SEQ ID NO: 13.

[0077] The genes encoding the above signal peptide, single-chain antibody targeting CD133, CD8α hin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a chimeric antigen receptor CAR-CD133 targeting CD133 and chimeric antigen receptor T cells targeting the CD133. The CAR-CD133 comprises amino acid sequences of a single-chain antibody targeting CD133, an extracellular hinge region, a transmembrane region and an intracellular signal region which are sequentially connected from an amino terminal to a carboxyl terminal. The CAR-CD133 can specifically target CD133, takes a CD27 signal region as a co-stimulation signal region, activates T cells to play a role in cellular immunity, promotes amplification of the T cells in a patient body, efficiently and specifically kills CD133 positive tumor cells, and has lasting cell viability and lethality. The invention also provides a preparation method of the chimeric antigen receptor T cells targeting the CD133, a recombinant virus vector with the CAR-CD133 coding gene, and the like.

Description

technical field [0001] The invention relates to the field of medical biology, in particular to a CD133-targeted chimeric antigen receptor, chimeric antigen receptor T cells, and a preparation method and application thereof. Background technique [0002] Malignant tumor (cancer) has become the culprit threatening human life, and the incidence rate is on the rise. For example, the incidence of colorectal cancer ranks second among malignant tumors in Western countries. Although radiotherapy, chemotherapy, and surgery have significantly prolonged the lives of patients, there are still problems such as easy tumor recurrence and serious side effects. Evidence shows that the reason for tumor recurrence is that there are rare cells with significant proliferation ability in the tumor cell population, which are called tumor stem cells. This group of cells can differentiate into new tumors. Only killing them in tumor treatment can Eliminate tumor recurrence, and completely cure the tu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N5/10C12N15/62C12N15/867A61K35/17A61P35/00
CPCA61K35/17A61P35/00C07K14/7051C07K16/2896C07K2317/622C07K2319/02C07K2319/03C07K2319/33C12N15/86C12N2510/02C12N2740/15043
Inventor 万晓春唐超
Owner SHENZHEN BINDEBIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products